125 related articles for article (PubMed ID: 15680136)
1. [Valvular heart disease associated with ergotamine].
Martínez Quintana E; Llorens León R; Redondo Martínez E; Nieto Lago V; Jiménez Cabrera F; Gross Kastanovitz E
Rev Esp Cardiol; 2005 Jan; 58(1):97-9. PubMed ID: 15680136
[TBL] [Abstract][Full Text] [Related]
2. Mitral and aortic valve disease associated with ergotamine therapy for migraine. Report of two cases and review of literature.
Hauck AJ; Edwards WD; Danielson GK; Mullany CJ; Bresnahan DR
Arch Pathol Lab Med; 1990 Jan; 114(1):62-4. PubMed ID: 2403780
[TBL] [Abstract][Full Text] [Related]
3. Images in clinical medicine. Four artificial heart valves.
Bijl M; van den Brink RB
N Engl J Med; 2005 Aug; 353(7):712. PubMed ID: 16107624
[No Abstract] [Full Text] [Related]
4. Aortic and mitral valve disease induced by ergotamine therapy for migraine: a case report and review of the literature.
Hendrikx M; Van Dorpe J; Flameng W; Daenen W
J Heart Valve Dis; 1996 Mar; 5(2):235-7. PubMed ID: 8665020
[TBL] [Abstract][Full Text] [Related]
5. Cardiac surgery for ergotamine-induced multivalvular heart disease.
Lazopoulos G; Papaioannou G; Kantartzis M
Thorac Cardiovasc Surg; 2013 Aug; 61(5):435-7. PubMed ID: 23475795
[TBL] [Abstract][Full Text] [Related]
6. [Ergotism caused by automedication].
Enríquez E; Rangel A; Velasco CE; Basave MN; López-Rodríguez R
Arch Inst Cardiol Mex; 2000; 70(6):603-8. PubMed ID: 11255720
[TBL] [Abstract][Full Text] [Related]
7. Ergotamine tartrate and dihydroergotamine mesylate: safety profiles.
Lipton RB
Headache; 1997; 37 Suppl 1():S33-41. PubMed ID: 9009472
[TBL] [Abstract][Full Text] [Related]
8. Hypnic headache associated with medication overuse: case report.
Baykan B; Ertaş M
Agri; 2008 Jul; 20(3):40-3. PubMed ID: 19085181
[TBL] [Abstract][Full Text] [Related]
9. Carotid artery dissection in ergotamine abuse.
Akova-Oztürk E; Husstedt IW; Ringelstein EB; Evers S
Headache; 2004 Oct; 44(9):930-2. PubMed ID: 15447707
[TBL] [Abstract][Full Text] [Related]
10. [Ergotamine-induced heart valve fibrosis and coronary microangiopathy?].
Creutzig A
Dtsch Med Wochenschr; 1992 Nov; 117(45):1736. PubMed ID: 1425287
[No Abstract] [Full Text] [Related]
11. Mitral, aortic and tricuspid valvular heart disease associated with ergotamine therapy for migraine.
Wilke A; Hesse H; Hufnagel G; Maisch B
Eur Heart J; 1997 Apr; 18(4):701. PubMed ID: 9129909
[No Abstract] [Full Text] [Related]
12. [Retroperitoneal fibrosis associated with chronic use of ergotamine: report of one case].
Vega J; Goecke H; Santamarina M
Rev Med Chil; 2011 Apr; 139(4):489-94. PubMed ID: 21879189
[TBL] [Abstract][Full Text] [Related]
13. Ergotamine-induced acute vascular insufficiency of the lower limb--a case report.
Halloul Z; Meyer F; Lippert H; Buerger T
Angiology; 2001 Mar; 52(3):217-21. PubMed ID: 11269787
[TBL] [Abstract][Full Text] [Related]
14. How can a migraine cause faecal incontinence?
Honein K; Boujaoude J; Chemaly M; Yaghi C; Karam R; Sayegh R
Gut; 2005 Dec; 54(12):1817, 1824. PubMed ID: 16284292
[No Abstract] [Full Text] [Related]
15. Reversal of ergotamine-induced vasospasm following methylprednisolone.
Rahman A; Yildiz M; Dadas E; Donder E; Cihangiroglu M; Eken C; Bozdemir MN
Clin Toxicol (Phila); 2008 Dec; 46(10):1074-6. PubMed ID: 18763151
[TBL] [Abstract][Full Text] [Related]
16. [Ergotamine-induced heart valve fibrosis].
Faber L
Dtsch Med Wochenschr; 1993 Feb; 118(6):205. PubMed ID: 8436073
[No Abstract] [Full Text] [Related]
17. [After the numerous ergotamine preparations are on the way out. Migraine patients to change over to triptans].
MMW Fortschr Med; 2003 Oct; 145(42):63. PubMed ID: 14655450
[No Abstract] [Full Text] [Related]
18. Ventricular fibrillation secondary to ergotamine in a healthy young woman.
Velez Roa S; Preumont N; Mols P; Stoupel E; Renard M
Acta Cardiol; 1999 Oct; 54(5):283-6. PubMed ID: 10596308
[TBL] [Abstract][Full Text] [Related]
19. Transcranial Doppler ultrasonographic features during drug withdrawal from drug-induced headache. A transcranial Doppler follow-up study.
Haase CG; Diener HC
Headache; 1998 Oct; 38(9):679-83. PubMed ID: 15613180
[TBL] [Abstract][Full Text] [Related]
20. [Retroperitoneal fibrosis secondary to ergotamine use].
Martín Azcárate MD; Hernández Muro G; Isusquiza I
An Med Interna; 2006 Apr; 23(4):193-4. PubMed ID: 16796416
[No Abstract] [Full Text] [Related]
[Next] [New Search]
